T2 Biosystems Inc EBITDA
Cos'è EBITDA di T2 Biosystems Inc?
EBITDA di T2 Biosystems Inc è -$42.13
Qual è la definizione di EBITDA?
L'EBITDA è il reddito di una società prima di interessi, imposte, deprezzamenti e ammortamenti ed è una misura contabile calcolata utilizzando gli utili netti di una società, prima che vengano sottratti interessi passivi, imposte, ammortamenti e ammortamenti come proxy della redditività corrente di un'azienda.
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
EBITDA di aziende nel Health Care settore su NASDAQ rispetto a T2 Biosystems Inc
Cosa fa T2 Biosystems Inc?
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
Aziende con ebitda simili a T2 Biosystems Inc
- Elmo Software ha EBITDA di -AUD$42.33
- Elmo Software ha EBITDA di -AUD$42.33
- CyberArk Software Ltd ha EBITDA di -$42.29
- Modern Healthcare Technology ha EBITDA di -HKD$42.23
- PAVmed ha EBITDA di -$42.20
- China Bozza Development ha EBITDA di -¥42.15
- T2 Biosystems Inc ha EBITDA di -$42.13
- Cardiol Therapeutics ha EBITDA di -CAD$42.12
- China Silver ha EBITDA di -¥41.98
- Culturecom ha EBITDA di -HKD$41.93
- 3D Systems ha EBITDA di -$41.72
- 3D Systems ha EBITDA di -$41.72
- Sterling ha EBITDA di -HKD$41.72